Resource Center
Find the latest content and resources from our team of experts to keep you in the know for all things quality and regulatory in the life science industry.
Sort by topic
Sort by resource type
Regulatory inspections are no longer isolated events tied to a single submission or approval milestone. Across ...
The European Commission’s Medical Device Coordination Group (MDCG) has issued new guidance clarifying how medical ...
Infant botulism occurs when spores of C. botulinum are ingested and produce toxins in an infant’s immature ...
As therapies become more complex, early regulatory engagement is no longer a best practice but a necessity. Cell ...
EMMA International announced the launch of its AI Solutions. This new offering is designed to help regulated ...
Regulatory intelligence goes beyond tracking new guidance. It involves systematically analyzing regulatory ...
US Food and Drug Administration has proactively added Janssen Pharmaceuticals’ combination therapy of teclistamab ...
The International Council for Harmonisation (ICH) is signaling a significant shift in how global regulatory ...
Regulatory requirements continue to evolve independently across regions, particularly for advanced therapies, ...
Global Capability Centers (GCCs) are becoming essential for life-sciences organizations navigating increasingly ...
A newly proposed draft guidance on the development of regenerative medicine therapies has prompted significant ...
The approval pathway for CAR T-cell therapies is entering a new phase as regulators signal a shift toward more ...
No results found.